スポンサーリンク
Division Of Medical Oncology Cancer Institute Hospital | 論文
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways
- Chemotherapy for Small-Bowel Adenocarcinoma at a Single Institution
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
- Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
- Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
- No CD117 expression on B progenitors in the regenerating bone marrow
- Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management